KATELYNN STICKLEY: Open Payments
NPI 1659945087 · PETERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 29 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $293 · 2025 $468
Food & beverage: $468
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| ABBVIE INC. | 12 | $136 |
| Novo Nordisk Inc | 4 | $69 |
| Amgen Inc. | 3 | $44 |
| Exact Sciences Corporation | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Alkermes, Inc. | 1 | $16 |
Products named: FARXIGA, VRAYLAR, Ozempic, OTEZLA, The Cologuard Plus Collection Kit, UBRELVY, AIRSUPRA, CAPLYTA.
Industry payments across WV — which companies pay providers there.
